Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors

Details for Australian Patent Application No. 2002230466 (hide)

Owner The Procter & Gamble Company

Inventors Sheldon, Russell James; Isfort, Robert Joseph

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002230466

PCT Pub. Number WO02/35240

Priority 09694519 23.10.00 US

Filing date 22 October 2001

Wipo publication date 6 May 2002

Acceptance publication date 24 March 2005

International Classifications

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

24 March 2005 Application Accepted

  Published as AU-B-2002230466

21 July 2005 Standard Patent Sealed

15 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002230467-System and methods for generating physican profiles concerning prescription therapy practices with self-adaptive predictive model

2002230465